JQDN

General

Cytokinetic Behavior Of Ehrlich Ascites Tumor After In Vivo

Di: Stella

Demonstration of repair of potentially lethal damage in plateau phase cells of Ehrlich ascites tumor after exposure to bleomycin.

Cytokinetic behavior of Ehrlich ascites tumor after in vivo treatment with cis-diamminedichloroplatinum (II) and metallocene dichlorides. A cytokinetic analysis has been made of 5-day and of 10-day old murine 6C3HED ascites lymphosarcoma (Gardner) by using a growth curve, percentage of labeled mitoses curves, and continuous labeling curves, which showed an increase in duration of the cell cycle and a slowing down of the growth rate. A cytokinetic analysis has been made of 5-day and of 10-day old

Cytokinetic analysis of tumor growth

PHARMACODYNAMIC EFFECT OF BEE VENOM NEW PREPARATIONS AGAINST

Köpf-Maier P, Wagner W, Liss E (1981b) Cytokinetic behavior of Ehrlich ascites tumor after in vivo treatment with cis-diaminedichloroplatinum (II) and metallocene dichlorides.

Cytokinetic behavior of Ehrlich ascites tumor after in vivo treatment with cis-diamminedichloroplatinum (II) and metallocene dichlorides 1 reference stated in Crossref reference URL retrieved 7 January 2021 based on heuristic inferred from DOI database lookup A procedure for data analysis of the rodent micronucleus test involving a historical Results of labeled mitoses and repeated labeling experiments are presented for the Ehrlich ascites tumor at 2, 6, and 10 days after implantation and a general method is outlined for calculating the rate of resorption of dead tissue from necrotic tumors. Experimental tumors have great importance in modeling, and Ehrlich ascites carcinoma (EAC) is one of the commonest tumors. EAC is referred to as an undifferentiated carcinoma and is originally hyperdiploid, has high transplantable capability, no-regression, rapid proliferation, shorter life span, 100% malignancy and also does not have tumor-specific transplantation

Evidence of spontaneous fusion between Ehrlich ascites tumor (EAT) cells and host cells in vivo was derived from the appearance of host-specific T6 chromosome markers in EAT cells after propagation in CBA/HT6 mice. After 1 year of weekly passages, these hybrids lost some unidentified chromosomes, so that their modal chromosome number reverted to the original

Cytokinetic behavior of Ehrlich ascites tumor after in vivo treatment with cis-diamminedichloroplatinum (II) and metallocene dichlorides P. Köpf-Maier, W. Wagner, E. Liss Biology, Medicine Journal of Cancer Research and Clinical Oncology 2004 Cytokinetic behavior of Ehrlich ascites tumor after in vivo treatment with cis-diamminedichloroplatinum (II) and metallocene dichlorides. Köpf-Maier were performed using P , Wagner W , Liss E Experimental tumors have great importance in modeling, and Ehrlich ascites carcinoma (EAC) is one of the commonest tumors. EAC is referred to as an undifferentiated carcinoma and is originally hyperdiploid, has high transplantable capability, no-regression, rapid proliferation, shorter life span, 100% malignancy and also does not have tumor-specific transplantation

  • Bis vanadium dichloride 95 12083-48-6
  • Cytokinetic analysis of tumor growth
  • CYTOKINETIC STABILITY OF AN EHRLICH ASCITES TUMOR

The cytokinetic response of Ehrlich ascites tumor (EAT) cells in vivo upon chronic treatment at low dosage levels with cytarabine (1-beta-D-arabinofuranosylcytosine, ara-c) bleomycin (BLM) and peplomycin (PEP) was estimated.

Cytokinetic behavior of Ehrlich ascites tumor after in vivo treatment with cis -diamminedichloroplatinum (II) and metallocene dichlorides P. Köpf-Maier W. Wagner E. Liss Original Papers Pages: 21 – 30

[Chromosome aberrations in ascites tumor cells of Ehrlich carcinoma in mice after irradiation in vivo at various oxygen partial pressure]

Spontaneous fusion between Ehrlich ascites tumor cells and host cells in vivo: kinetics of hybridization, and concurrent changes in the histocompatibility profile of the Cytokinetic behavior of Ehrlich ascites tumor after in vivo treatment with cis-diamminedichloroplatinum (II) and metallocene dichlorides. A cytokinetic analysis has been made of 5-day and of 10-day old murine 6C3HED ascites lymphosarcoma (Gardner) by using a growth curve, percentage of labeled mitoses curves, and continuous labeling curves.

Summary A cytokinetic analysis has been made of 5-day and of 10-day old murine 6C3HED ascites lymphosarcoma (Gardner) by using a growth curve, percentage of labeled mitoses curves, and continuous labeling curves. The doubling time increased from 36 h in the proliferative phase of growth to 252h in the stationary phase. The slowing down of the growth rate was due to

Considering the cytokinetic behavior of EAT cells after in vivo treatment, however, there are pronounced and surprising differences between TDC, VDC, and DDP (K6pf-Maier et al. 1981 b). The present narrative review discusses characteristics of the Ehrlich tumor model, laboratory manipulations of and is originally hyperdiploid has Ehrlich cells (ECs), and applications in pharmacological, pathological, and FIG. 1 – Growth curve of the 6C3HED ascites lymphosarcoma in C3H mice after inoculation of 1 X 107 cells, with mean number of 3 to 5 mice. – „Cytokinetic Analysis at Various Ages of an Ascites Tumor after Radiation“

Ehrlich cell The tumor was cultured in vivo, which became known as the Ehrlich cell. After 1948 Ehrlich cultures spread around research institutes all over the world. The Ehrlich cell became popular because it could be expanded by in vivo passage. This made it useful for biochemical studies involving large amounts of tissues. 3 In vitro behavior of Ehrlich ascites tumor cells (EATC) after downregulation of GA by transfection with an antisense-Gls expressing construct . ( a ) EATC transfected with the pcDNA3 vector

Cytokinetic behavior of Ehrlich ascites tumor after in vivo treatment with cis-diamminedichloroplatinum (II) and metallocene dichlorides. Köpf-Maier P, Wagner W, Liss E. J Cancer Res Clin Oncol. 1981;102 (1):21-30. doi: 10.1007/BF00410531. Cytokinetic behavior of Ehrlich ascites tumor after in vivo treatment with cis-diamminedichloroplatinum (II) and metallocene dichlorides P. Köpf‐MaierW. WagnerE. Liss Biology, Medicine Journal of Cancer Research and Clinical Oncology 2004 Cytokinetic behavior of Ehrlich ascites tumor after in vivo treatment with cis -diamminedichloroplatinum (II) and metallocene dichlorides P. Köpf-Maier W. Wagner E. Liss Original Papers Pages: 21 – 30

Iman E. O. Gomaa, Mona B. Mohamed, Tarek A. El-Tayeb In vivo experiments were performed using Ehrlich ascites tumor cells. These are transplantable, poorly differentiated malignant tumor cells that appeared originally as a spontaneous tumor cells breast adenocarcinoma in albino mice. Semantic Scholar extracted view of “ [Cytokinetic effect of bleomycin on mouse Ehrlich carcinoma in vivo. Possibilities of tumor cell synchronization for radiotherapy].“ by J. Schumann et al.

Spontaneous fusion between Ehrlich ascites tumor cells and host cells in vivo: kinetics of hybridization, and concurrent changes in the histocompatibility profile of the Cytokinetic behavior of Ehrlich ascites tumor with the pcDNA3 vector Cytokinetic after in vivo treatment with cis-diamminedichloroplatinum (II) and metallocene dichlorides. Köpf-Maier P, Wagner W, Liss E J Cancer Res Clin Oncol, 102 (1):21-30, 01 Jan 1981 Cited by: 8 articles | PMID: 7199526

Spontaneous fusion between Ehrlich ascites tumor cells and host cells in vivo: kinetics of hybridization, and concurrent changes in the histocompatiblity profile of the tumor after propagation in different host strains. ABSTRACT An Ehrlich ascites tumor has maintained much of its cytokinetic stability through multiple passages which included a change in host. Evidence of spontaneous fusion between Ehrlich ascites tumor (EAT) cells and host cells in vivo was derived from the appearance of host-specific T6 chromosome markers in EAT cells after propagation in CBA/HT6 mice. After 1 year of weekly passages, these hybrids lost some unidentified chromosomes, so that their modal chromosome number reverted to the original

Cytokinetic behavior of Ehrlich ascites tumor after in vivo treatment with cis -Diamminodichloroplatinum (II) and Metallocene Dichloride J. Cancer Res. Clin. Oncol., 201 (1981), pp. 21 – 30 Cytokinetic behavior of Ehrlich ascites tumor after in vivo treatment with cis-diamminedichloroplatinum (II) and metallocene dichlorides.